Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel.
Dorota DanielakMarta Karaźniewicz-ŁadaKarolina WiśniewskaPiotr BergusPaweł BurchardtAnna KomosaFranciszek GłówkaPublished in: European journal of drug metabolism and pharmacokinetics (2017)
CYP3A4*1G might not be a significant contributor to the variability in pharmacokinetic and pharmacodynamic response to clopidogrel therapy.